Skip to content

Psilocybin rapidly, but not immediately, reverses reward learning deficits in a durable manner in an inflammatory rat model of depressive symptoms

Justyna K. Hinchcliffe, Christopher W. Thomas, Gary Gilmour, Emma Robinson

bioRxiv (Cold Spring Harbor Laboratory) January 15, 2026 preprint DOI: 10.64898/2026.01.14.699553 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Animal study
Population Rats with chronic interferon-alpha-induced depression
Intervention Psilocybin
Dose 0.3 mg/kg
Duration 24 hours to at least 7 days
Topics Psilocybin Serotonin
Keywords Antidepressant Anhedonia Rat model Depression economics Imipramine Pharmacology Hallucinogen Depressive symptoms
Key points Acute psilocybin (0.3 mg/kg) reverses impaired reward-induced biases within 24 hours, with effects enduring for at least 7 days in a rat model of depression.

Abstract

Abstract The serotonergic psychedelic, psilocybin, shows potential for rapid and sustained antidepressant effects but the underlying mechanisms remain unknown. Using a chronic interferon-alpha–induced rat model of depression, we show acute psilocybin (0.3 mg/kg) reverses impaired reward-induced biases within 24hrs, with effects enduring for at least 7 days. This suggests psilocybin can restore blunted reward processing, an effect which could significantly contribute to its sustained antidepressant effects.

Comparable studies

Other preclinical and animal studies on psilocybin, most cited first.

Citations in the library

Explore topics